133 related articles for article (PubMed ID: 25981745)
21. [From diffuse goiter to nodular goiter].
Derwahl M
Internist (Berl); 1998 Jun; 39(6):577-83. PubMed ID: 9677512
[No Abstract] [Full Text] [Related]
22. Effect of thyroidectomy on circulating angiogenic cytokines in papillary thyroid carcinoma and benign goiter: Potential for new biomarkers?
Ria R; Prete F; Melaccio A; Di Meo G; Saltarella I; Solimando AG; Gurrado A; Ferraro V; Pasculli A; Sgaramella LI; Racanelli V; Vacca A; Testini M
Surgery; 2021 Jan; 169(1):27-33. PubMed ID: 32482341
[TBL] [Abstract][Full Text] [Related]
23. Upregulation of endocrine gland-derived vascular endothelial growth factor in papillary thyroid cancers displaying infiltrative patterns, lymph node metastases, and BRAF mutation.
Pasquali D; Santoro A; Bufo P; Conzo G; Deery WJ; Renzullo A; Accardo G; Sacco V; Bellastella A; Pannone G
Thyroid; 2011 Apr; 21(4):391-9. PubMed ID: 21385081
[TBL] [Abstract][Full Text] [Related]
24. Circulating levels of PTEN and KLLN in papillary thyroid carcinoma: can they be considered as novel diagnostic biomarkers?
Razavi SA; Modarressi MH; Yaghmaei P; Tavangar SM; Hedayati M
Endocrine; 2017 Sep; 57(3):428-435. PubMed ID: 28755140
[TBL] [Abstract][Full Text] [Related]
25. Incidental thyroid cancer in toxic and nontoxic goiter: Is TSH associated with malignanCy rate? Results of a meta-analysis.
Negro R; Valcavi R; Toulis KA
Endocr Pract; 2013; 19(2):212-8. PubMed ID: 23186976
[TBL] [Abstract][Full Text] [Related]
26. MiR-204-5p suppresses cell proliferation by inhibiting IGFBP5 in papillary thyroid carcinoma.
Liu L; Wang J; Li X; Ma J; Shi C; Zhu H; Xi Q; Zhang J; Zhao X; Gu M
Biochem Biophys Res Commun; 2015 Feb; 457(4):621-6. PubMed ID: 25603050
[TBL] [Abstract][Full Text] [Related]
27. Thymosin beta 10 correlates with lymph node metastases of papillary thyroid carcinoma.
Zhang XJ; Su YR; Liu D; Xu DB; Zeng MS; Chen WK
J Surg Res; 2014 Dec; 192(2):487-93. PubMed ID: 24974154
[TBL] [Abstract][Full Text] [Related]
28. [
Zhang X; Su X; Chen WC; Li Y; Yang ZY; Deng WZ; Deng TC; Yang AK
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 52(6):435-439. PubMed ID: 28635216
[No Abstract] [Full Text] [Related]
29. Cathepsin B activity and protein levels in thyroid carcinoma, Graves' disease, and multinodular goiters.
Shuja S; Cai J; Iacobuzio-Donahue C; Zacks J; Beazley RM; Kasznica JM; O'Hara CJ; Heimann R; Murnane MJ
Thyroid; 1999 Jun; 9(6):569-77. PubMed ID: 10411119
[TBL] [Abstract][Full Text] [Related]
30. An InDel in Phospholipase-C-B-1 Is Linked with Euthyroid Multinodular Goiter.
Bakhsh AD; Ladas I; Hamshere ML; Bullock M; Kirov G; Zhang L; Taylor PN; Gregory JW; Scott-Coombes D; Völzke H; Teumer A; Mantripragada K; Williams ED; Clifton-Bligh RJ; Williams NM; Ludgate ME
Thyroid; 2018 Jul; 28(7):891-901. PubMed ID: 29897006
[TBL] [Abstract][Full Text] [Related]
31. Fibroblast growth factors 1 and 2 and fibroblast growth factor receptor 1 are elevated in thyroid hyperplasia.
Thompson SD; Franklyn JA; Watkinson JC; Verhaeg JM; Sheppard MC; Eggo MC
J Clin Endocrinol Metab; 1998 Apr; 83(4):1336-41. PubMed ID: 9543164
[TBL] [Abstract][Full Text] [Related]
32. Trends in white blood cell and platelet indices in a comparison of patients with papillary thyroid carcinoma and multinodular goiter do not permit differentiation between the conditions.
Machairas N; Kostakis ID; Prodromidou A; Stamopoulos P; Feretis T; Garoufalia Z; Damaskos C; Tsourouflis G; Kouraklis G
Endocr Res; 2017 Nov; 42(4):311-317. PubMed ID: 28506088
[TBL] [Abstract][Full Text] [Related]
33. Differential expression of miRNAs in papillary thyroid carcinoma compared to multinodular goiter using formalin fixed paraffin embedded tissues.
Tetzlaff MT; Liu A; Xu X; Master SR; Baldwin DA; Tobias JW; Livolsi VA; Baloch ZW
Endocr Pathol; 2007; 18(3):163-73. PubMed ID: 18058265
[TBL] [Abstract][Full Text] [Related]
34. Thyroid autoimmunity: is really associated with papillary thyroid carcinoma?
Selek A; Cetinarslan B; Tarkun I; Canturk Z; Ustuner B; Akyay Z
Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1677-1681. PubMed ID: 27933384
[TBL] [Abstract][Full Text] [Related]
35. Altered expression of the gap junction protein connexin43 is associated with papillary thyroid carcinomas when compared with other noncancer pathologies of the thyroid.
Dominguez C; Karayan-Tapon L; Desurmont T; Gibelin H; Crespin S; Fromont G; Levillain P; Bouche G; Cantereau A; Mesnil M; Kraimps JL
Thyroid; 2011 Oct; 21(10):1057-66. PubMed ID: 21875346
[TBL] [Abstract][Full Text] [Related]
36. Activation of signal transducer and activator of transcription 3 by oncogenic RET/PTC (rearranged in transformation/papillary thyroid carcinoma) tyrosine kinase: roles in specific gene regulation and cellular transformation.
Hwang JH; Kim DW; Suh JM; Kim H; Song JH; Hwang ES; Park KC; Chung HK; Kim JM; Lee TH; Yu DY; Shong M
Mol Endocrinol; 2003 Jun; 17(6):1155-66. PubMed ID: 12637586
[TBL] [Abstract][Full Text] [Related]
37. The incidence of thyroid carcinoma in multinodular goiter: prospective study.
Pradhan GB; Shrestha R; Shrestha S; Neupane J; Bhattachan CL
Nepal Med Coll J; 2011 Sep; 13(3):169-71. PubMed ID: 22808807
[TBL] [Abstract][Full Text] [Related]
38. [Expression and significance of serum E-cadherin in patients with papillary thyroid carcinoma].
Sun L; Wang DM; Zhang WJ; Zhang J; Wu JF
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 31(2):123-126. PubMed ID: 29871201
[No Abstract] [Full Text] [Related]
39. Id1 gene expression is up-regulated in hyperplastic and neoplastic thyroid tissue and regulates growth and differentiation in thyroid cancer cells.
Kebebew E; Peng M; Treseler PA; Clark OH; Duh QY; Ginzinger D; Miner R
J Clin Endocrinol Metab; 2004 Dec; 89(12):6105-11. PubMed ID: 15579766
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing SMAD4 in thyroid cancer.
Geraldo MV; Yamashita AS; Kimura ET
Oncogene; 2012 Apr; 31(15):1910-22. PubMed ID: 21874046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
